Stifel Financial
PACB icon

Stifel Financial’s Pacific Biosciences PACB Stock Holding History

Stifel Financial’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Sell
68,249
-1,777
-3% -$2.58K ﹤0.01% 3602
2026
Q1 		$92.4K Sell
70,026
-834
-1% -$1.49K ﹤0.01% 3541
2025
Q4 		$133K Buy
70,860
+16,151
+30% +$31K ﹤0.01% 3452
2025
Q3 		$70K Sell
54,709
-2,403
-4% -$3.25K ﹤0.01% 3472
2025
Q2 		$70.8K Sell
57,112
-2,420
-4% -$2.79K ﹤0.01% 3387
2025
Q1 		$70.3K Sell
59,532
-7,999
-12% -$12.3K ﹤0.01% 3320
2024
Q4 		$124K Buy
67,531
+16,843
+33% +$32.9K ﹤0.01% 3231
2024
Q3 		$86.2K Buy
50,688
+6,129
+14% +$10.1K ﹤0.01% 3261
2024
Q2 		$61K Sell
44,559
-11,515
-21% -$23.3K ﹤0.01% 3262
2024
Q1 		$210K Sell
56,074
-77,800
-58% -$456K ﹤0.01% 3080
2023
Q4 		$1.31M Buy
133,874
+37,556
+39% +$307K ﹤0.01% 1973
2023
Q3 		$804K Buy
96,318
+11,219
+13% +$128K ﹤0.01% 2190
2023
Q2 		$1.13M Sell
85,099
-864
-1% -$10.5K ﹤0.01% 2007
2023
Q1 		$995K Sell
85,963
-16,685
-16% -$166K ﹤0.01% 2065
2022
Q4 		$840K Sell
102,648
-5,416
-5% -$46.7K ﹤0.01% 2131
2022
Q3 		$627K Buy
108,064
+10,310
+11% +$59.2K ﹤0.01% 2294
2022
Q2 		$432K Buy
97,754
+7,185
+8% +$43.7K ﹤0.01% 2553
2022
Q1 		$824K Buy
90,569
+25,316
+39% +$291K ﹤0.01% 2255
2021
Q4 		$1.33M Sell
65,253
-62,514
-49% -$1.51M ﹤0.01% 1907
2021
Q3 		$3.26M Sell
127,767
-1,160
-0.9% -$34.4K ﹤0.01% 1263
2021
Q2 		$4.51M Buy
128,927
+19,903
+18% +$579K 0.01% 1073
2021
Q1 		$3.63M Buy
109,024
+73,343
+206% +$2.57M 0.01% 1141
2020
Q4 		$926K Buy
+35,681
New +$606K ﹤0.01% 1900

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Stifel Financial's PACB Position: Q2 2026 in Review

Stifel Financial reduced its Pacific Biosciences (PACB) stake by 2.5% in Q2 2026, selling an estimated $2.58K and leaving 68,249 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #3602.

Stifel Financial first reported a position in PACB in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.51M in Q2 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Stifel Financial held 68,249 shares of Pacific Biosciences worth $115K as of Q2 2026.
  • Stifel Financial sold 1,777 Pacific Biosciences shares in Q2 2026, an estimated $2.58K.
  • Pacific Biosciences made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3602 holding.
  • Stifel Financial first reported a position in Pacific Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Stifel Financial's Pacific Biosciences position peaked at $4.51M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.